Mecripyrine Hydrochloride

盐酸美可比林

Report date: 2023/12/08 17:18:08
NME

Base Information

Drug NameMecripyrine Hydrochloride
Drug Alias NameSCR-1693Y-1AY-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitorsMicrotubule-associated protein tau inhibitors
TargetsAcetylcholinesteraseMicrotubule-associated protein tau
Therapy Area/IndicationsAlzheimer DiseaseBrain Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Simcere Pharmaceutical Co LtdYantai Yene Pharma Co LtdNeuroDawn Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesNeuroDawn Pharmaceutical Co LtdJiangsu Ouwei Pharmaceutical Co LtdJiangsu Simcere Pharmaceutical Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseBrain Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A